With the increasing rate of cardiovascular disease constant innovation and advancement in technology has become paramount. In the field of coronary artery bypass grafting (CABG) introduction of endoscopic vessel harvesting system market has open up newer opportunities for companies. Coronary artery bypass graft surgery (CABG) is a procedure for restoring the blood supply to the heart muscle due to blockage or narrowing of one or more coronary arteries. Traditionally, the technique involved in harvesting procedure was open vein harvesting (OVH) which involved a single continuous skin incision. With the recent advancement in technology, the process is less invasive by endoscopic vessel harvesting (EVH) this technique reduces leg wound morbidity because of small incisions compared to open vein harvesting. Endoscope is a medical instrument used for capturing a picture inside a hollow area, which is connected to a video camera and inserted through a small incision that is made in the leg. The saphenous vein inside the leg is viewed by the endoscope and helps the surgeon in identifying and to remove the vein with minimal pain to the leg.
According to Center of Disease Control and Prevention, around 3,95,000 CABG surgeries were performed in the United States in 2013. The endoscopic vessel harvesting system market is mainly driven by the incidence and prevalence rate of coronary diseases. Moreover due to benefits such as less invasive modality, including a lower infection rate, fewer wound complications, improved cosmesis, and greater patient satisfaction physicians and patients are opting for this treatment. High pool of geriatric population and awareness programs among surgeons will drive the endoscopic vessel harvesting system market. However, endoscopic vessel harvesting system market has some restraints, lack of skilled professionals in the developing countries and unstable reimbursement regulations are hampering the growth of endoscopic vessel harvesting system in developing countries. Apart from this the presence of alternative therapies may hinder the growth of the endoscopic vessel harvesting systems market.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1620
The Global endoscopic vessel harvesting system market is segmented on the basis of product type and regional presence:
Segmentation based on product type
Geographically the endoscopic vessel harvesting system market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region.
CABG is most common type of heart surgery performed in North America region as per University of Michigan. North America followed by Europe are currently leading in the endoscopic vessel harvesting system market as high incidence of coronary disease due to sedentary lifestyle pattern adopted in these region and availability of all the types of minimally invasive CABG surgeries. The endoscopic vessel harvesting system market in Asia Pacific is expected to deliver tremendous growth due to the growth in per capita income in Asian countries and increase in medical tourism industry. With the growing access of public with healthcare professional and expanding economy china is expected to be the fastest growing market for endoscopic vessel harvesting system.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1620
Some major companies in the endoscopic vessel harvesting system market are Maquet Holding B.V. & Co. KG., OLYMPUS CORPORATION, Terumo Cardiovascular Systems Corporation., Med Europe S.r.l. (Elite Life Care), Sorin Group Inc., Saphena Medical, Inc and Terumo Cardiovascular Systems Corporation.